Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (CURLF) is a global leader in consumer cannabis products, serving medical and adult-use markets through innovative cultivation and distribution networks. This page provides investors and industry observers with direct access to official company announcements, regulatory updates, and strategic developments.
Track Curaleaf's operational milestones through verified press releases, earnings reports, and partnership announcements. Key updates include product launches across its Select, Grassroots, and JAMS brands, regulatory compliance achievements, and market expansion initiatives in North America and Europe.
All content is sourced from Curaleaf's corporate communications and vetted financial disclosures, offering reliable insights into their vertically integrated operations. Discover updates on cultivation technologies, retail expansions, and quality control advancements that maintain their position as a cannabis industry pioneer.
Bookmark this page for streamlined access to Curaleaf's latest hemp-derived product developments, financial performance data, and corporate governance updates. Regularly updated to reflect new entries in their official news archive.
Curaleaf has expanded its Grassroots brand into New Jersey, introducing premium cannabis flower and pre-rolls in the state. This marks New Jersey as the eighth market for Grassroots products following the brand's national rebranding in November 2022. Five strains, including Novarine and Jelly Cocktail, are now available, aiming to attract both medical patients and adult-use customers. Grassroots products utilize high-quality genetics for a superior experience and are now offered at all Curaleaf locations in New Jersey. CEO Matt Darin emphasizes the brand's commitment to quality as it seeks to resonate with New Jersey's cannabis community.
Curaleaf Holdings announced the opening of its new Palm Beach Gardens dispensary and the launch of BlueKudu chocolate products in Florida. The dispensary, located at 3540 Northlake Blvd., will open on January 13, expanding Curaleaf's retail footprint to 56 locations in the state and 146 nationwide. The new BlueKudu flavors, espresso dark chocolate and caramel milk chocolate, will also be available for preorder. A grand opening celebration is set for January 20, featuring giveaways and local vendors.
Curaleaf Holdings announces participation in key investor conferences in January 2023. CEO Matt Darin will engage in fireside chats at the ICR Conference on January 10 and the Needham Growth Conference on January 12, as well as a panel discussion at the ATB Capital Markets' Institutional Investor Conference on the same day. Curaleaf continues to expand its presence in the cannabis market, operating 145 dispensaries across 21 states in the U.S. and being a leading player in Europe. For more details, visit their investor relations site.
Curaleaf Holdings (CURLF) has announced the appointment of Michelle Bodner and Shasheen Shah to its Board of Directors, effective December 31, 2022. Bodner brings extensive experience in operations and executive coaching, having previously served in various roles within Curaleaf. Shah, a leadership development coach, will also add strategic insights to the board. With these additions, the board now has eight members, including four independent directors. This move aims to enhance governance as Curaleaf prepares for its 2023 initiatives.
Curaleaf Holdings announced a groundbreaking partnership between its Grassroots brand and Ganjier, launching a unique cannabis education program. This initiative aims to elevate the cannabis industry's standards through training for 100 nominated team members and external partners. The program incorporates a comprehensive online curriculum, culminating in an in-person training session in Humboldt, California. The Grassroots brand is operational in seven states and focuses on high-quality cannabis products, aligning with Curaleaf's commitment to cannabis education and professionalism.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) has announced its participation in investor conferences in December 2022. CEO Matt Darin will engage in a fireside chat at Cowen's 5th Annual Cannabis Conference on December 6, followed by a lunch panel at Stifel Canada's 3rd Annual Future of Healthcare Conference on December 7. Curaleaf is recognized as a leader in the cannabis sector, operating 144 dispensaries across 21 states and being the largest vertically integrated cannabis company in Europe. For more details, visit Curaleaf's Investor Relations website.